UK report gives thumbs up to generic HIV drugs used as PrEP

A sexual health clinic in London has tested drug levels in users of generic PrEP medication bought online and found the drugs are genuine and effective.

Tests found adequate levels of both emtricitabine and tenofovir (used in PrEP medication Truvada) in patients’ blood, and no sample suggesting counterfeit drugs.

Blood donor restrictions for gay men should be removed, Victorian Government says

ABC, 7.10.16

he Victorian Government has called on its federal counterpart to end the ban on men who have sex with men from donating blood.

Key points:

  • Current restrictions prevent men from donating blood within 12 months of having sex with another man
  • State and federal ministers have agreed to review the national donation policy in 2017
  • According to the Red Cross, the risk of infection from a blood donation is less than one in 1 million

 

Read more here

Small risk of sexual transmission of HIV persists through first six months of ART

nam/aidsmap, 10 May 2016

A risk of HIV transmission to sexual partners persists for six months after the initiation of antiretroviral therapy, investigators from a large prospective prevention study confirm in the online edition of the Journal of Acquired Immune Deficiency Syndromes.

Over 1,500 serodiscordant heterosexual couples were included in the analysis. Initiation of antiretroviral therapy (ART) was accompanied by a fall in the risk of transmission, but the risk persisted during the first six months of treatment. No transmissions were observed once patients had been taking treatment for over six months.

Read more here

Almost-certain case of PrEP failure due to drug resistance

nam/aidsmap, 25 February 2016

A case report of a man in Toronto who became infected with a multi-drug-resistant strain of HIV despite apparently very consistent adherence to PrEP was presented at the CROI 2016 conference in Boston today.

Read more here

HIV-infected vaginal cells do not transmit HIV if plasma viral load is undetectable

nam/aidsmap, 15 February 2016

A group of researchers have cleared up an important question about HIV transmission, in experiments on mice. Although HIV-infected CD4 cells persist in the vagina even on antiretroviral therapy (ART) that fully suppresses free HIV in the blood and body fluids, these cells are not anything like numerous enough to pose any transmission threat.

Read more here